Impact of Cannabis Use, Substance Use Disorders, and Psychiatric Diagnoses on COVID-19 Outcomes: A Retrospective Cohort Study
Identifying risk factors that predispose individuals to negative COVID-19 outcomes is important. The current study examined the association between substance use disorders, psychiatric diagnosis, and COVID-19–related clinical outcomes.
Category
  • Psychotic Disorders
  • Substance Use Disorders
  • COVID-19
Format
  • Journal
Credits
  • AMA PRA Category 1 Credit™
  • Participation
The Co-occurrence of Gastrointestinal Symptoms and Psychosis: Diagnostic Considerations
There are numerous clinical scenarios in which gastrointestinal and psychotic symptoms commonly co-occur; thus, it is important that both psychiatrists and primary care physicians have a familiarity with the differential diagnosis.
Category
  • Psychotic Disorders
  • Gastroenterology
Format
  • Journal
Credits
  • AMA PRA Category 1 Credit™
  • Participation
Predictors of Bipolar Disorder Versus Schizophrenia Diagnosis in a Multicenter First Psychotic Episode Cohort: Baseline Characterization and a 12-Month Follow-Up Analysis
What features may predict bipolar disorder vs schizophrenia in a person with first-episode psychosis? In this journal CME activity, find out which tools could most aid diagnosis.
Category
  • Psychotic Disorders
  • Schizophrenia/ Schizoaffective Disorders
  • Bipolar Disorder
  • Diagnostic Tools
Format
  • Journal
Credits
  • AMA PRA Category 1 Credit™
  • Participation
Relieving Caregiver Burden Through Evidence-Based Treatment for Dementia-Related Psychosis
Dementia-related psychosis (DRP) occurs in all forms of dementia and at all stages. What tactics should be used when talking with patients and their care partners about DRP? How is it best treated?
Category
  • Dementia
  • Geriatric Psychiatry
  • Psychotic Disorders
Format
  • Self-study / Enduring
Credits
  • AMA PRA Category 1 Credit™
  • Participation
Addressing Patients’ Unmet Needs to Improve Outcomes in Schizophrenia
What are some of the challenges you face in overcoming adherence issues and providing patient-centered care for people living with schizophrenia? Drs Harvey and Kane offer evidence and clinical experience on these topics in this journal CME activity.
Category
  • Adherence
  • Antipsychotics
  • Delivery of Care
  • Psychotic Disorders
  • Schizophrenia/ Schizoaffective Disorders
  • Side Effects
Format
  • Self-study / Enduring
Credits
  • AMA PRA Category 1 Credit™
  • Participation
Part 3: Impact of Side Effects on Adherence to Schizophrenia Treatment
Side effects from medication have the greatest impact on adherence for patients with Schizophrenia. They lower quality of life, daily functioning, and satisfaction.
Category
  • Adherence
  • Antipsychotics
  • Cognition
  • Neuropsychiatric Disorders
  • Patient/Physician Communication
  • Psychopharmacology
  • Psychotic Disorders
  • Schizophrenia/ Schizoaffective Disorders
  • Sexual Dysfunction
  • Side Effects
  • Veterans and Military Issues
Format
  • Self-study / Enduring
  • Video
Credits
  • AMA PRA Category 1 Credit™
  • Participation
Part 1: A Review of Schizophrenia
Schizophrenia affects 1% of the world’s population largely during a patient’s most productive years. Multiple treatments are available, however many gaps to recovery exist. Learn from experts diagnostic criteria for and defining recovery in schizophrenia.
Category
  • Adherence
  • Antipsychotics
  • Cognition
  • Neuropsychiatric Disorders
  • Patient/Physician Communication
  • Psychopharmacology
  • Psychotic Disorders
  • Schizophrenia/ Schizoaffective Disorders
  • Sexual Dysfunction
  • Side Effects
  • Veterans and Military Issues
Format
  • Self-study / Enduring
  • Video
Credits
  • AMA PRA Category 1 Credit™
  • Participation
Part 2: Chasing Cognitive and Negative Symptoms: Unmet Treatment Needs of Patients with Schizophrenia
Negative symptoms contribute to poor functional outcomes in schizophrenia. Evaluating different symptom domains and understanding the disorder’s reward circuitry can help with intervention and patients’ leading more fulfilling lives.
Category
  • Adherence
  • Antipsychotics
  • Cognition
  • Neuropsychiatric Disorders
  • Patient/Physician Communication
  • Psychopharmacology
  • Psychotic Disorders
  • Schizophrenia/ Schizoaffective Disorders
  • Sexual Dysfunction
  • Side Effects
  • Veterans and Military Issues
Format
  • Self-study / Enduring
  • Video
Credits
  • AMA PRA Category 1 Credit™
  • Participation
Part 4: Balancing Safety and Efficacy with Novel Schizophrenia Treatments
Balancing symptoms and side effects is difficult when treating patients with schizophrenia. New approaches to treatment and new therapies in the pipeline offer hope for this difficult-to-treat mental health disorder.
Category
  • Adherence
  • Antipsychotics
  • Cognition
  • Neuropsychiatric Disorders
  • Patient/Physician Communication
  • Psychopharmacology
  • Psychotic Disorders
  • Schizophrenia/ Schizoaffective Disorders
  • Sexual Dysfunction
  • Side Effects
  • Veterans and Military Issues
Format
  • Self-study / Enduring
  • Video
Credits
  • AMA PRA Category 1 Credit™
  • Participation
Measurement-Based Care for Psychotic Disorders in the Veterans Health Administration: Current Practices and Future Directions
Measurement-based care (MBC) can improve patient outcomes, but data on its use in psychosis are sparse. This study examined the use of patient-reported outcome measures in veterans with psychosis to identify candidate measures for psychosis-related MBC.
Category
  • Psychotic Disorders
  • Veterans and Military Issues
Format
  • Journal
Credits
  • AMA PRA Category 1 Credit™
  • Participation

Pages